Stock News & Analysis

Will the 20th time be the charm?

This biotech stock could soar 30% or more over the next 12 months if some analysts are right.

Anthropic could go public as soon as the week of Nov. 9.

History shows that Trump’s proposed payout would hinder, not help, the U.S. economy and stock market.

Amazon is seeing tremendous growth in all three areas.

Pivot away from big tech with these three blue chip dividend stocks.

The Google parent came within 3% of the level in May. Can it close a far wider gap by the end of 2027?

How exposed are shareholders if one of its two largest customers pulls back?

SpaceX's upcoming earnings update could tell us a little more about its prospects.

Forecasts of doom and gloom due to rate hikes have been heavily overstated.

Fidelity offers lower costs and steadier returns, while State Street targets smaller biotech companies with higher volatility and recent outperformance.

VHT offers broad sector exposure, while IBB concentrates on biotech with higher growth but steeper drawdowns.

Warren Buffett has weathered many stock market crashes over his years of investing.

For those waiting for a Nike turnaround, it looks like there's more waiting ahead.

Looking past Walmart just because of its yield could be a mistake.

Nvidia and AMD are two great semiconductor stocks to buy and hold for the long term.

This nuclear company boasts a strong moat and should benefit from growing support for nuclear energy.

Peter Thiel has scored some big wins as a tech investor and company founder, but that doesn't mean everything he touches will turn to gold.

HPE stock soared last month on booming AI data center demand. Here's what drove the rally and why the enterprise computing giant's valuation still looks reasonable.

Don't get your hopes up.